288 related articles for article (PubMed ID: 2998540)
1. Five cases of cyclical Cushing's syndrome.
Atkinson AB; Kennedy AL; Carson DJ; Hadden DR; Weaver JA; Sheridan B
Br Med J (Clin Res Ed); 1985 Nov; 291(6507):1453-7. PubMed ID: 2998540
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the use of urinary cortisol to creatinine ratios and nocturnal salivary cortisol in the evaluation of cyclicity in patients with Cushing's syndrome.
Graham UM; Hunter SJ; McDonnell M; Mullan KR; Atkinson AB
J Clin Endocrinol Metab; 2013 Jan; 98(1):E72-6. PubMed ID: 23150688
[TBL] [Abstract][Full Text] [Related]
3. Cortisol-suppressible dexamethasone-nonsuppressible cyclic Cushing's disease with evidence of clinical and biochemical remission with bromocriptine.
Mercado-Asis LB; Murayama M; Yamakita N; Morita H; Mune T; Yasuda K; Miura K
Endocrinol Jpn; 1991 Jun; 38(3):315-24. PubMed ID: 1665413
[TBL] [Abstract][Full Text] [Related]
4. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
5. The effect of cyproheptadine and/or bromocriptine on plasma ACTH levels in patients cured of Cushing's disease by bilateral adrenalectomy.
Whitehead HM; Beacom R; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 1990 Feb; 32(2):193-201. PubMed ID: 2161298
[TBL] [Abstract][Full Text] [Related]
6. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
[TBL] [Abstract][Full Text] [Related]
8. Effect of bromocriptine in pituitary-dependent Cushing's syndrome.
Boscaro M; Benato M; Mantero F
Clin Endocrinol (Oxf); 1983 Oct; 19(4):485-91. PubMed ID: 6313262
[TBL] [Abstract][Full Text] [Related]
9. Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation.
Tucci JR; Nowakowski KJ; Jackson IM
J Endocrinol Invest; 1989 Mar; 12(3):197-200. PubMed ID: 2542391
[TBL] [Abstract][Full Text] [Related]
10. Cyclical Cushing's disease and its successful control under sodium valproate.
Beckers A; Stevenaert A; Pirens G; Flandroy P; Sulon J; Hennen G
J Endocrinol Invest; 1990 Dec; 13(11):923-9. PubMed ID: 2090672
[TBL] [Abstract][Full Text] [Related]
11. [Cushing's syndrome: diagnostic exploration].
Tabarin A; Roger P
Presse Med; 1994 Jan 8-15; 23(1):43-8. PubMed ID: 8127815
[TBL] [Abstract][Full Text] [Related]
12. Cyclic Cushing's disease in long-term remission with a daily low dose of bromocriptine.
Adachi M; Takayanagi R; Yanase T; Sakai Y; Ikuyama S; Nakagaki H; Osamura Y; Sanno N; Nawata H
Intern Med; 1996 Mar; 35(3):207-11. PubMed ID: 8785455
[TBL] [Abstract][Full Text] [Related]
13. [Unique type of Cushing's disease in clinical profile: cyclic Cushing's syndrome and Cushing's disease with favorable outcome to a high daily dose of bromocriptine].
Yasuda K; Miura K
Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):11-6. PubMed ID: 7958078
[TBL] [Abstract][Full Text] [Related]
14. Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease.
Koppeschaar HP; Croughs RJ; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1983 Oct; 104(2):160-3. PubMed ID: 6314723
[TBL] [Abstract][Full Text] [Related]
15. [Effect of cyproheptadine on plasma ACTH and cortisol secretion in a patient with Cushing's disease].
Esposito V; D'Alessandro B; Bellastella A; Iacono G; Bizzarro A; Officioso A; Piccolo C
Boll Soc Ital Biol Sper; 1976 Nov; 52(22):1901-5. PubMed ID: 194608
[No Abstract] [Full Text] [Related]
16. Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.
Pieters GF; Smals AG; Goverde HJ; Pesman GJ; Meyer E; Kloppenborg PW
J Clin Endocrinol Metab; 1982 Dec; 55(6):1188-97. PubMed ID: 6290524
[TBL] [Abstract][Full Text] [Related]
17. Six year remission of ACTH-dependent Cushing's syndrome using bromocriptine.
Atkinson AB; Kennedy AL; Sheridan B
Postgrad Med J; 1985 Mar; 61(713):239-42. PubMed ID: 2984649
[TBL] [Abstract][Full Text] [Related]
18. Cushing's disease: clinical and laboratory response to bromocriptine therapy.
de Pinho MO; Antunes RC; Lima MB; Francalanci CC; Franco S
J Endocrinol Invest; 1984 Dec; 7(6):585-8. PubMed ID: 6099377
[TBL] [Abstract][Full Text] [Related]
19. The 10:00-11:00 pm urine cortisol/creatinine ratio. An alternative to late-night salivary cortisol for the diagnosis of Cushing's syndrome.
Bruno OD; Rossi MA; Juárez-Allen L; Serra HA; Albiero MC
Medicina (B Aires); 2015; 75(6):373-8. PubMed ID: 26707659
[TBL] [Abstract][Full Text] [Related]
20. Variability in laboratory parameters used for management of Cushing's syndrome.
Pecori Giraldi F; Ambrogio AG
Endocrine; 2015 Dec; 50(3):580-9. PubMed ID: 26160393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
